asrm_logo_color_tagline.png
Menu

ASRM QBoost

Sign ups are on hiatus until April 2023
View the ASRM QBoost FAQs below

Level up your knowledge of ASRM’s committee documents!

ASRM’s member benefit will help you learn and retain information important to your practice.

Introducing ASRM QBoost, a platform that tests your knowledge of ASRM committee documents two questions at a time via your email or mobile device.

QBoost uses an educational strategy known as spaced learning, which is popular because it’s fun and increases content retention. Answer questions at your convenience, in short time spurts, such as in between retrievals, or at your child’s soccer practice.

QBoost is free for ASRM members and currently offers 40+ question banks to choose from.

QBOOSTQBoost is an ASRM members-only benefit. If you would like to sign up for QBoost, please login or consider becoming a member of ASRM.

QBoost Question Banks

AZOOSPERMIA

Source material: Evaluation of the azoospermic male: a Practice Committee opinion Fertil Steril 2018;109:777–82
Intended audience: All (REI fellows, REI physicians, nurses, lab, urologists, mental health professionals)
Description: This question bank reviews the current methods of diagnosis and evaluation for men with azoospermia.

DIAGNOSTIC EVALUATION OF THE INFERTILE MALE

Source material: Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion Fertil Steril 2018;110:833–7
Intended audience: All
Description: This question bank explores the diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion. It is the responsibility of the clinician to assess for the presence of erectile dysfunction, ejaculatory dysfunction, or diminished libido 
related to hypoandrogenism among men presenting with a primary complaint of infertility. Referral to a reproductive urologist or other appropriate specialist with requisite expertise in the evaluation and treatment of such conditions is often warranted.
Sample Question: https://www.surveymonkey.com/r/9GWHTJS

DISCLOSURE OF SEX AS PART OF PGT

Source material: Disclosure of sex when incidentallyrevealed as part of preimplantation genetic testing (PGT): an EthicsCommittee opinion Fertil Steril 2018;110:625–7
Intended audience: All
Description: This question bank is based on the Disclosure of sex when incidentally revealed as part of preimplantation genetics testing (PGT): an Ethics Committee opinion that reviews how clinics may develop a policy to disallow selecting which embryos to transfer based on sex and choose to use only embryo quality as selection criteria. Clinics may also develop a policy to use randomization to select those embryos for transfer if more embryos suitable for transfer are available than can be transferred.

ETHICAL EMBRYO RESEARCH

Source material: Ethics in embryo research: a positionstatement by the ASRM Ethics inEmbryo Research Task Force and the ASRM Ethics Committee Fertil Steril 2020;113:270–94
Intended audience: All
Description: Ethics in Embryo Research: A question bank based on a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee. Abstract: Scientific research using human embryos advances human health and offspring well-being and provides vital insights into the mechanisms for reproduction and disease. Research involving human embryos is ethically acceptable if it is likely to provide significant new knowledge that may benefit human health, well-being of the offspring, or reproduction.
Sample Question:https://www.surveymonkey.com/r/QB61520

EXOGENOUS GONADOTROPINS FOR OVULATION INDUCTION

Source material: Use of exogenous gonadotropins forovulation induction in anovulatorywomen: a committee opinion Fertil Steril 2020;113:66–70
Intended audience: All
Description: This question bank reviews gonadotropin treatment for ovulation induction in anovulatory women and the rec­ommended pretreatment evaluation, indications, treatment regimens, and complications of gonadotropin treatment.
Sample Question: https://www.surveymonkey.com/r/QBDEC20

FEMALE INFERTILITY

Source material: Obesity and reproduction: a Practice Committee opinion Fertil Steril 2015;104:1116–26
Intended audience: All (also available in Spanish)
Description: This question bank provides a comprehensive report on the principles and strategies for the evaluation of couples with infertility associated with obesity.

FERTILITY DRUGS AND CANCER

Source material: Fertility Drugs and Cancer: a guideline Fertil Steril 2016;106:1617–26
Intended audience: All
Description: This question bank focuses on the methodological limitations in studying the association between the use of fertility drugs and cancer. Given the available literature, patients should be counseled that infertile women may be at an increased risk of invasive ovarian, endometrial, and breast cancer; however, use of fertility drugs does not appear to increase this risk.
Sample Question: https://www.surveymonkey.com/r/N9LSLWX

FERTILITY PRESERVATION

Source material: Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion Fertil Steril 2018;110:380–6
Intended audience: All
Description: Chemotherapy and radiation therapy often result in reduced fertility. Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring.
Sample Question:https://www.surveymonkey.com/r/QBMay21

FERTILITY TREATMENT WHEN THE PROGNOSIS IS VERY POOR OR FUTILE

Source material: Fertility treatment when theprognosis is very poor or futile: an Ethics Committee opinion Fertil Steril 2019;111:659–63
Intended audience: All
Description: This question bank explores the Ethics Committee's recommendations on the development of evidence-based policies that are patient-centered for each in vitro fertilization (IVF) center. In most cases, the provision of futile therapies is not ethically justifiable. For those treatments with very poor success rates, clinicians must be vigilant in their presentation of risks, benefits, and alternatives.
Sample Question: https://www.surveymonkey.com/r/QB0721

INFERTILITY WORKUP

Source material: Infertility Workup for the Women’s Health Specialist Obstet Gynecol 2019;133:e377–84
Intended audience: All
Description: Infertility, defined as failure to achieve pregnancy within 12 months of unprotected intercourse or therapeutic donor insemination in women younger than 35 years or within 6 months in women older than 35 years, affects up to 15% of couples. This question bank explores the essential components of an initial workup, which include a review of the medical history, physical examination, and additional tests as indicated. This question bank is based on the Infertility workup for the woman’s health specialist: ACOG committee opinion.

INFORMING OFFSPRING OF THEIR CONCEPTION BY DONOR GAMETE OR EMBRYO DONATION

Source material: Informing offspring of theirconception by gamete or embryodonation: an EthicsCommittee opinion Fertility and Sterility 2018; 109(4): 601-605.
Intended audience: All 
Description: The question bank explores the discussion of the ethical implications of informing offspring about their conception using gamete or embryo donation. It replaces the 2013 ASRM Ethics Committee document of the same name.

INTERESTS, OBLIGATIONS, AND RIGHTS IN GAMETE AND EMBRYO DONATION

Source material: Interests, obligations, and rights ingamete and embryo donation: an Ethics Committee opinion Fertil Steril 2019;111:664–70
Intended audience: All
Description: This question bank reviews the interests, obligations, and rights of all parties involved in gamete and embryo donation: both males and females who choose to provide gametes or embryos for use by others, recipients of donated gametes and embryos, individuals born as a result of gamete or embryo donation, and the programs that provide donated gametes and embryos to patients.
Sample Question: https://www.surveymonkey.com/r/QBapr21

MINIMAL STIMULATION

Source material: Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a Practice Committee guideline Fertil Steril 2018;109:993–9
Intended audience: All
Description: This is a short 7-question bank that evaluates pregnancy and live-birth rates in patients expected to be poor responders using mild ovarian stimulation and natural-cycle protocols vs conventional IVF.
Sample Question: https://www.surveymonkey.com/r/NCFF27W

OHSS

Source material: Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline Fertil Steril 2016;106:1634–47
Intended audience: All
Description: Ovarian hyperstimulation syndrome (OHSS) is an uncommon but serious complication associated with assisted reproductive technology (ART). This question bank explores the systematic review that aims to identify who is at high risk, how to prevent OHSS, and the treatment for existing OHSS.
Sample Question: https://www.surveymonkey.com/r/XBYXCTG

OPTIMIZING NATURAL FERTILITY AND VACCINES FOR FEMALE INFERTILITY
Source material:
Intended audience: All
Description: This question bank combines two committee opinions to explore optimizing natural fertility and recommendations for vaccines for female infertility patients.
Sample Question: https://www.surveymonkey.com/r/QBApr2020
PCOS INTERNATIONAL RECOMMENDATIONS

Source material: Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome FertilSteril 2018;110:364–79
Intended audience: All
Description: This question bank explores the comprehensive evidence-based guideline that builds on prior high-quality guidelines and culminates from a rigorous, Appraisal of Guidelines for Research and Evaluation-II (AGREEII)-compliant, evidence-based guideline development process. It provides a single source of international evidence-based recommendations to guide clinical practice with the opportunity for adaptation in relevant health systems.
Sample Question: https://www.surveymonkey.com/r/NKYCQ2Y

PLANNED OOCYTE CRYOPRESERVATION

Source material: Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion.
Webinar: Planned Oocyte Cryopreservation: Medical, Ethical and Social Considerations Fertil Steril 2018;110:1022–8
Intended audience: All 
Description: This question bank addresses an emerging but ethically permissible procedure that may help women avoid future infertility. Because planned OC is new and evolving, it is essential that women who are considering using it be informed about the uncertainties regarding its efficacy and long-term effects.
Sample Question: https://www.surveymonkey.com/r/NY6HP6P

ROLE OF METFORMIN IN PCOS

Source material: Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a Practice Committee guideline Fertil Steril 2017;108:426–41
Intended audience: All
Description: Does metformin alone compared with placebo increase the ovulation rate in women with PCOS? Are oral ovulation induction agents alone much more effective in increasing ovulation, pregnancy, and live-birth rates in women with PCOS? Enroll in this question bank to take a deeper dive.

TRANSFERRING EMBRYOS WITH GENETIC ANOMALIES

Source material: Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion Fertil Steril 2017;107:1130–5
Intended audience: All
Description: Patient requests for transfer of embryos with genetic anomalies linked to serious health-affecting disorders detected in preimplantation testing are rare but do exist. This Opinion sets out the possible rationales for a provider's decision to assist or decline to assist in such transfers. The Committee concludes in most clinical cases it is ethically permissible to assist or decline to assist in transferring such embryos. In circumstances in which a child is highly likely to be born with a life-threatening condition that causes severe and early debility with no possibility of reasonable function, provider transfer of such embryos is ethically problematic and highly discouraged.

UTERINE SEPTUM

Source material: Uterine Septum: a guideline Fertil Steril 2016;106:530–40
Intended audience: All
Description: The Uterine Septum guideline reviews the literature regarding septate uterus and determines optimal indications and methods of treatment for it.
Sample Question: https://www.surveymonkey.com/r/XFQW7ZT

Read More

NPG QBoost Question Banks

Nurse Practitioners: Diagnosis and treatment of infertility in Men

Source material: Diagnosis and treatment of infertility in men
Target audience:Nurse Practitioners
Description: a. This question bank explores updated, evidence-based recommendations regarding evaluation of male infertility as well as the association of male infertility with other important health conditions, according to the diagnosis and treatment of infertility in Men: AUA/ASRM Guidelines and briefly examines recurrent pregnancy loss, DNA fragmentation and other genetic issues.
Author: Elizabeth Sanderman, RN

Nurse Practitioners: Mosaicism
Source material:  Target audience: Nurse Practitioners
Description: This question bank explores two documents developed by the ASRM. First, a document that reviews the available literature and outlines the various issues surrounding the reporting of intermediate copy number and consideration of storage or transfer of blastocysts with intermediate copy number results. Second, the opinions that sets out the possible rationales for a provider's decision to assist or decline to assist in such transfers. The ASRM Committee concludes in most clinical cases it is ethically permissible to assist or decline to assist in transferring such embryos.
Author: Kathy Bugge, RN


Nurse Practitioners: Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy

Source material: Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion
Target audience: All
Description: This question bank reviews the counseling process regarding available options for fertility preservation for iatrogenic infertility for patients preparing to undergo gonadotoxic medical therapy, radiation therapy, or gonadectomy.
Author: Rebecca Brodie, RN

Nurse Practitioners: Carrier Screening for Genetic Conditions

Source material: Carrier Screening for Genetic Conditions
Target audience: Nurse Practitioners
Description: This question bank reviews the recommendations and conclusions provided by The American College of Obstetricians and Gynecologists (the College) regarding carrier screening for genetic conditions.
Author: Svetlana Izrailevsky, RN

Read More

Resident QBoost Question Banks

Resident Education: Pediatric Gynecology

Source material: Resident Education Module RES000: Pediatric Gynecology
Target audience:All
Description:The most common pediatric gynecologic problem is vulvovaginitis. This condition is an inflammation of the vulvar and vaginal tissue, and accounts for as many as 50% of outpatient pediatric gynecologic visits. This question bank is based on RES000 Pediatric Gynecology course.
Link to QBoost Bank: https://asrm.qstream.com/courses/35954.

Resident Education: Galactorrhea/ Hyperprolactinemia
Source material:  Resident Education Module: Galactorrhea/Hyperprolactinemia (RES008)
Target audience: All
Description: Galactorrhea is a sign of elevated prolactin levels that are increased by both physiologic and pathologic dopamine-suppression mechanisms. Galactorrhea frequently, but not consistently, occurs with hyperprolactinemia. Galactorrhea requires the presence of estrogen and progesterone, and occurs in premenopausal women, and may be associated with mastalgia. Physiologic galactorrhea may persist up to one year post-lactation. This question bank explores the module on Galactorrhea/Hyperprolactinemia (RES008) that describes the causes of galactorrhea /hyperprolactinemia, and discusses the importance of history and physical, diagnostic studies, while providing treatment options and surgical options for treatment of pituitary adenoma as well as long-term follow-up recommendations.
Link to QBoost Bank: https://asrm.qstream.com/courses/35953 
Resident Education: Reproductive Endocrinology –
Infertility Evaluation Part I

Source material: CREOG Unit 5, Reproductive Endocrinology, Section IV: Infertility, Subsection A: Infertility Evaluation
Target audience: ObGyn Residents
Description: This question bank reviews the OBGyn Resident course work on Infertility Evaluation - Part I

Learning objectives are:
  • Describe the classification and principal causes of infertility.
  • Elicit a pertinent history and list the components of a focused physical examination to evaluate infertility.
  • Select and interpret diagnostic tests to determine the most likely cause of infertility.
  • Describe appropriate treatment for infertile patients who have irregular ovulation with nongonadotropin therapy.
  • Describe appropriate surgical procedures to correct anatomic conditions that cause infertility.
  • Counsel patients about the prognosis for their condition and alternatives to childbearing such as adoption, donor gametes, and use of a surrogate or gestational carrier.
  • Describe the indications for referral to a subspecialist for treatment.
Link to QBoost Bank: https://asrm.qstream.com/courses/35585
Resident Education: Reproductive Endocrinology –
Infertility Evaluation Part II

Source material: CREOG Unit 5, Reproductive Endocrinology, Section IV: Infertility, Subsection A: Infertility Evaluation
Target audience: ObGyn Residents
Description: This question bank reviews the OBGyn Resident course work on Infertility Evaluation - Part II

Learning objectives are:
  • Describe the classification and principal causes of infertility.
  • Elicit a pertinent history and list the components of a focused physical examination to evaluate infertility.
  • Select and interpret diagnostic tests to determine the most likely cause of infertility.
  • Describe appropriate treatment for infertile patients who have irregular ovulation with nongonadotropin therapy.
  • Describe appropriate surgical procedures to correct anatomic conditions that cause infertility.
  • Counsel patients about the prognosis for their condition and alternatives to childbearing such as adoption, donor gametes, and use of a surrogate or gestational carrier.
  • Describe the indications for referral to a subspecialist for treatment.
Link to QBoost Bank: https://asrm.qstream.com/courses/35719
Read More

ASRM QBoost FAQs

HOW DO I REGISTER TO QBOOST?

STEP 1: To get started, you will need to login into your ASRM membership account. Click on the ‘Sign up/ Sign in for ASRM QBoost’ tab at the top of this page or click on ‘Access your account’ tab on the right side of this page.

STEP 2: On the QStream page, to sign up as a first-time user, enter your email address (use a personal one like a Gmail or Yahoo), enter your password and confirm, your first and last name. Click Sign in to create an account on the question bank platform, QStream.

Click on the “Complete Registration” link provided to you by email. To keep it simple, you may want to enter the same password you use for the ASRM website. We also recommend that you bookmark the QStream link for easy access.

HOW DO I ENROLL IN A QUESTION BANK IN QBOOST?

There are a few extra steps to enroll in a question bank:

Step 1: On the left panel on the QStream page click ‘Browse the QStream directory’, this will open a page with question banks, to see the full suite of banks available, click ‘Browse all QStreams’.

Place your mouse over each bank and hover over them to read a snapshot of the question bank and if its intended for you (some are resident question banks).

Click on a question bank of your choice, click ‘Enroll now for FREE’, on the next page you’ll review your notification options, and click ‘Enroll’ (at the bottom of the page).

Remember to enroll in ONE question bank at a time to avoid being deluged by multiple email/ app notifications.

I HAVE A TECHNICAL ISSUE / I HAVE A QBOOST RELATED QUESTION

Please contact Sarah Ramaiah at sramaiah@asrm.org for any issues with login, password reset or problems enrolling in a new bank.

HOW DO I DOWNLOAD THE APP?

There are 3 steps before you download the APP:

Step 1: Register – sign up for ASRM QBoost
Step 2: Enroll in a question bank
Step 3: Go to the APP STORE/ PLAY STORE
Search QSTREAM
Click GET/ DOWNLOAD

HOW DO I MANAGE EMAIL/ APP NOTIFICATIONS?

To activate or deactivate email/ app notification, you can log into your QStream account and click on ‘Update notification settings.’ Here you can choose the appropriate option.

If at any time, you want to turn off push notifications, you can do so from your device settings. However, if you only want to suspend questions on the weekend or while on vacation, it is recommended that you log in to your QStream account online, click on My Dashboard, and then Account Settings. Here you can opt in or out of weekend notifications or click the Update Notification Settings button to schedule a vacation hold. Taking this step allows you suspend push notifications without permanently turning them off.

When you set up the app for the first time, you’ll be asked if you want to allow push notifications. A push notification alerts you when questions in your question bank are available to answer by displaying them on your home screen. We recommend allowing push notifications because the only action you need to take is swiping the question and marking your response.

Push notifications tell you when you have new questions. If your push notification disappears, don’t worry. You can still answer questions by opening the QStream app, tapping the menu icon, and looking under Today’s Questions.

I WANT TO SEE MY DETAILED QSTREAM REPORT?

To view the detailed QStream report, log into your QStream account, click on ‘My Dashboard’ and on the right under your progress section click on ‘View detailed report’ which provides a detailed description of the questions you have answered, the answer status, result and date/ time of taking the questions.

 

Read More

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew

ASRM Members:

Click for Sign Up Instructions

QBoost Sign Up Instructions